Summary Choriocarcinoma can be imaged by external scintigraphy after intravenous administration of radiolabelled antibody directed against human chorionic gonadotrophin (HCG). The purpose of this study was to investigate whether antibody imaging was sufficiently sensitive and specific to improve the selection of patients for surgical resection of localised deposits of drug resistant or recurrent choriocarcinoma. Eighteen patients with raised serum HCG concentrations in whom the site of tumour was not known were investigated by antibody imaging and conventional imaging methods. When the tumour appeared localised, resection was attempted. Tumour was found at all sites in which both antibody imaging and conventional imaging methods were positive. Antibody imaging gave false positive results in 2 of 18 patients and false negatives in 5. Computerised tomography was false positive in one case and false negative in 2. In these patients, antibody imaging gave true negative and true positive results respectively. Of 8 patients with positive antibody imaging in whom resection was attempted, 5 achieved sustained complete response with up to five years follow up. It is concluded that antibody imaging is useful in selection of patients for surgery in drug resistant or recurrent choriocarcinoma.
Although the majority of patients with choriocarcinoma are curable with chemotherapy, drug resistant tumour is still the major cause of death (Begent & Bagshawe, 1982) . Some of these patients have localised disease which can be cured by surgical resection, usually combined with adjuvant chemotherapy. Success of this strategy depends on accurate localisation of the tumour and on discrimination between viable tumour masses and the residual non-viable masses often found at sites from which choriocarcinoma has been eradicated. The presence of drug resistant choriocarcinoma is demonstrable by measurement of serum human chorionic gonadotrophin (HCG) concentrations. The sensitivity of this test exceeds that of any present imaging method so that patients with drug resistant choriocarcinoma are seen with rising serum HCG values but no clear indication of the site of active tumour. Antibody imaging, in which tumours are imaged by external scintigraphy after intravenous injection of radiolabelled antibody directed against HCG provides a way of locating these tumours and demonstrating HCG production at the site concerned. Earlier studies of antibody imaging have shown that large deposits of choriocarcinoma can be located and that the sensitivity was sometimes sufficient to make the investigation useful in clinical decision making (Begent et al., 1980; Goldenberg et al., 1980 Goldenberg et al., , 1981 .
This paper describes a study in which antibody imaging was performed in patients with drug resistant or recurrent choriocarcinoma in whom there was a rise in serum HCG values but the site of tumour was not known. The results were compared with those of conventional imaging methods and assessed for their value in selection of patients for surgery.
Materials and methods

Antibodies
The details of the antibodies directed against HCG, their purification and radiolabelling have been described previously Begent et al., 1980 Goldenberg et al. (1978) . Numerical analysis of areas of relative accumulation of 1311 antibody on the subtraction image was performed by the method of Green et al. (1984) . In brief, regions of interest were drawn around the suspect area and around an apparently normal area in the same organ or tissue. The ratio of counts of 1311 in the two regions was compared with that of 99mTc in the same regions. The difference between the two ratios was expressed in terms of standard deviations known as an Fx value. Areas known to produce artefacts in subtraction imaging such as the urinary bladder, heart and lower border of the liver (Begent, 1985) were excluded from analysis.
Results
Eighteen patients with drug resistant or recurrent choriocarcinoma in whom the site of tumour was not known were studied. In nine patients the antibody was of sheep and in nine of mouse monoclonal origin. No difference was seen between the images with the two reagents. Numerical analysis of images was performed by the method of Green et al. (1984) in 12 of these. The remaining 6 patients were studied before this method was devised and the data were acquired in a form which was not analysable. The results of the numerical analysis are shown in Figure 1 . Sites at which tumour was later found tended to have higher Fx values than other sites at which no tumour was found. If an Fx value of +4 or greater is considered positive this gives a predictive value of a positive:
True + ve 9 True + ve + false + ve o 1 The value of surgery to such patients depends on whether they attain a sustained complete remission. Five of the eight patients with positive antibody imaging whose tumours were resected achieved this as shown in Table III . Figure 2 shows an example of antibody imaging in which the tumour was located and resected leading to complete response. Figure 3 shows the effect of resection of choriocarcinoma in another patient where all other means of imaging had failed to locate the tumour.
The higher the Fx value, the greater was the probability that the result was a true positive. It should also be noted that 50% of tumour sites gave false negative results.
Interpretation of the earlier studies which could not be analysed by the Fx method was done subjectively using the experience gained from the Fx studies.
The results of antibody imaging were compared with the findings of computerised tomography (CT), ultrasound and subsequent surgery. The results are shown in Table I Antibody imaging can be difficult to interpret, particularly when small tumours are being sought. The Fx method (Green et al., 1984) has done much to resolve this problem by providing an objective means of interpretation and giving the result in numerical terms so that the probability of a result being correct can be calculated.
There are other ways in which antibody imaging may be improved such as by use of IIt-Indium labelled antibodies (Rainsbury et al., 1983; Fairweather et al., 1983; Buckley & Searle, 1984) , 123-Iodine labelled antibodies F(ab) fragments (Mach et al., 1980; Buchegger et al., 1983; Chatal et al., 1984; Larson et al., 1983) and second antibody . These topics and the relative merits of monoclonal and polyclonal antibodies have been discussed previously (Begent, 1985) . As antibody imaging develops so other imaging methods are also likely to advance and the selection of patients for surgery to improve further.
The proportion of patients with choriocarcinoma whose disease is not eradicated by chemotherapy is small but some of these can be cured by the additional use of surgery (Begent & Bagshawe, 1982) . Antibody imaging makes a valuable contribution by enhancing our ability to locate viable tumour and improving selection for surgery.
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